Yuhan Corporation launches renewed Rapicall Power cold medicine line

Yuhan Corporation has launched three renewed versions of its over-the-counter cold medicine line, branded as ‘Rapicall Power Soft Capsules’. The new lineup includes ‘Rapicall Power Cold’ for general symptoms, ‘Rapicall Power Cough’ for throat issues, and ‘Rapicall Power Nose’ for nasal congestion.

The updated products feature an increased dosage of acetaminophen, rising from 200mg to 250mg per capsule. When taken according to the adult dosage of two capsules three times a day, this reaches the maximum daily limit of 1,500mg for adults and those aged 15 and older, intended to provide stronger antipyretic and analgesic effects.

Additionally, the ‘Rapicall Power Cold’ and ‘Rapicall Power Cough’ variants now include 2mg of bromhexine hydrochloride per capsule alongside the existing guaifenesin to improve the management of phlegm. The packaging has also been expanded from 10 capsules to 12 capsules per unit, providing a full two-day supply for adults to improve consumer convenience.